News
MicroTransponder has posted one-year follow-up data for its FDA-approved device, two months after securing $65m in Series F ...
The US Food and Drug Administration (FDA) has set an "aggressive" timeline to implement genAI across the agency by 30 June ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results